President Donald Trump signed a sweeping executive order lowering prescription drug prices through a “Most Favored Nation” policy in a move that is legally dubious and is sure to face fierce opposition from pharmaceutical companies.

President Donald Trump signed an executive order Monday that he said will slash drug prices by approximately 59% or more

The proposal would see the HHS set price targets other countries pay for certain medicines, kicking off a round of discussions with substantial ramifications for drugmakers. It’s likely to be challenged in court,